(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]sulfonyl}-2-oxo-1,3-oxazolidine-3-carboxamide

(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]sulfonyl}-2-oxo-1,3-oxazolidine-3-carboxamide

The title compound, C21H21N3O7S, contains an oxazolidinone ring and a sulfonamide group, both characteristic for biologically and pharrmaceutically active compounds. Both stereogenic centres reveal an S absolute configuration. The two oxazolidinone rings are in an envelope conformation with the meth...

Full description

Bibliographic Details
Main Authors: Malika Berredjem, Assia Allaoui, Amani Direm, Noureddine Aouf, Nourredine Benali-Cherif
Format: Article
Language:English
Published: International Union of Crystallography 2010-07-01
Series:Acta Crystallographica Section E
Online Access:http://scripts.iucr.org/cgi-bin/paper?S1600536810020866

Internet

http://scripts.iucr.org/cgi-bin/paper?S1600536810020866

Similar Items